Avanos Medical, Inc. (AVNS)
NYSE: AVNS · Real-Time Price · USD
14.21
-0.12 (-0.84%)
Apr 1, 2025, 10:43 AM EDT - Market open

Avanos Medical Statistics

Total Valuation

Avanos Medical has a market cap or net worth of $653.70 million. The enterprise value is $721.73 million.

Market Cap 653.70M
Enterprise Value 721.73M

Important Dates

The next estimated earnings date is Thursday, May 1, 2025, before market open.

Earnings Date May 1, 2025
Ex-Dividend Date n/a

Share Statistics

Avanos Medical has 46.00 million shares outstanding. The number of shares has decreased by -1.29% in one year.

Current Share Class 46.00M
Shares Outstanding 46.00M
Shares Change (YoY) -1.29%
Shares Change (QoQ) -1.29%
Owned by Insiders (%) 1.74%
Owned by Institutions (%) 88.40%
Float 42.19M

Valuation Ratios

PE Ratio n/a
Forward PE 12.74
PS Ratio 0.96
Forward PS 0.95
PB Ratio 0.79
P/TBV Ratio 2.53
P/FCF Ratio 7.95
P/OCF Ratio 6.55
PEG Ratio 1.46
Financial Ratio History

Enterprise Valuation

The stock's EV/EBITDA ratio is 7.99, with an EV/FCF ratio of 8.71.

EV / Earnings n/a
EV / Sales 1.05
EV / EBITDA 7.99
EV / EBIT 16.11
EV / FCF 8.71

Financial Position

The company has a current ratio of 2.37, with a Debt / Equity ratio of 0.21.

Current Ratio 2.37
Quick Ratio 1.45
Debt / Equity 0.21
Debt / EBITDA 1.63
Debt / FCF 2.05
Interest Coverage 3.67

Financial Efficiency

Return on equity (ROE) is -37.42% and return on invested capital (ROIC) is 2.29%.

Return on Equity (ROE) -37.42%
Return on Assets (ROA) 1.97%
Return on Invested Capital (ROIC) 2.29%
Return on Capital Employed (ROCE) 4.53%
Revenue Per Employee $308,846
Profits Per Employee -$176,066
Employee Count 2,227
Asset Turnover 0.48
Inventory Turnover 2.03

Taxes

Income Tax -17.00M
Effective Tax Rate n/a

Stock Price Statistics

The stock price has decreased by -28.03% in the last 52 weeks. The beta is 1.17, so Avanos Medical's price volatility has been higher than the market average.

Beta (5Y) 1.17
52-Week Price Change -28.03%
50-Day Moving Average 15.61
200-Day Moving Average 19.50
Relative Strength Index (RSI) 39.57
Average Volume (20 Days) 529,126

Short Selling Information

The latest short interest is 796,523, so 1.73% of the outstanding shares have been sold short.

Short Interest 796,523
Short Previous Month 706,950
Short % of Shares Out 1.73%
Short % of Float 1.89%
Short Ratio (days to cover) 1.62

Income Statement

In the last 12 months, Avanos Medical had revenue of $687.80 million and -$392.10 million in losses. Loss per share was -$8.53.

Revenue 687.80M
Gross Profit 381.30M
Operating Income 44.80M
Pretax Income 14.70M
Net Income -392.10M
EBITDA 90.30M
EBIT 44.80M
Loss Per Share -$8.53
Full Income Statement

Balance Sheet

The company has $107.70 million in cash and $170.20 million in debt, giving a net cash position of -$62.50 million or -$1.36 per share.

Cash & Cash Equivalents 107.70M
Total Debt 170.20M
Net Cash -62.50M
Net Cash Per Share -$1.36
Equity (Book Value) 828.50M
Book Value Per Share 18.03
Working Capital 227.50M
Full Balance Sheet

Cash Flow

In the last 12 months, operating cash flow was $100.70 million and capital expenditures -$17.80 million, giving a free cash flow of $82.90 million.

Operating Cash Flow 100.70M
Capital Expenditures -17.80M
Free Cash Flow 82.90M
FCF Per Share $1.80
Full Cash Flow Statement

Margins

Gross margin is 55.44%, with operating and profit margins of 6.51% and -57.01%.

Gross Margin 55.44%
Operating Margin 6.51%
Pretax Margin -58.64%
Profit Margin -57.01%
EBITDA Margin 13.13%
EBIT Margin 6.51%
FCF Margin 12.05%

Dividends & Yields

Avanos Medical does not appear to pay any dividends at this time.

Dividend Per Share n/a
Dividend Yield n/a
Dividend Growth (YoY) n/a
Years of Dividend Growth n/a
Payout Ratio n/a
Buyback Yield 1.29%
Shareholder Yield 1.29%
Earnings Yield -59.48%
FCF Yield 12.58%

Analyst Forecast

Price Target n/a
Price Target Difference n/a
Analyst Consensus Hold
Analyst Count 1
Revenue Growth Forecast (5Y) n/a
EPS Growth Forecast (5Y) n/a
Stock Forecasts

Stock Splits

This stock does not have any record of stock splits.

Last Split Date n/a
Split Type n/a
Split Ratio n/a

Scores

Avanos Medical has an Altman Z-Score of 1.74 and a Piotroski F-Score of 6. A Z-score under 3 suggests an increased risk of bankruptcy.

Altman Z-Score 1.74
Piotroski F-Score 6